SCHEMBL7141176

SCHEMBL7141176

Cc1ccc(CCNCc2cccc(-c3cnc(-c4ccc(F)cc4)[nH]3)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP3A4 P08684 1/20 0.46
SSTR3 P32745 3/20 0.44
BACE1 P56817 1/20 0.41
HPGDS O60760 2/20 0.41
NPY5R Q15761 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP2C9 P11712 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
ROCK1 Q13464 1/20 0.40
SCN2A Q99250 3/20 0.39
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138024 0.92 SSTR3 (0.47) SSTR3BACE1HPGDSNPY5RROCK1
SCHEMBL7138181 0.92 HPGDS (0.49) CYP1A2CYP2D6CYP2C19CYP3A4BACE1
SCHEMBL8118487 0.91 CYP1A2 (0.41) CYP1A2CYP2D6CYP2C19CYP3A4SSTR3
SCHEMBL7143626 0.86 BACE1 (0.45) BACE1HPGDSNPY5RSCN2A
SCHEMBL7179734 0.84 BACE1 (0.47) BACE1HPGDSNPY5RSCN2A
SCHEMBL8110914 0.83 CYP1A2 (0.44) CYP1A2CYP2D6CYP2C19BACE1HPGDS
SCHEMBL7140173 0.83 BACE1 (0.43) BACE1HPGDSNPY5RSCN2A
SCHEMBL7135108 0.82 CYP1A2 (0.46) CYP1A2CYP2D6CYP2C19BACE1HPGDS
SCHEMBL7140310 0.82 HTR1A (0.44) CYP1A2CYP2D6CYP2C19CYP3A4BACE1
SCHEMBL7187293 0.81 BACE1 (0.44) SSTR3BACE1HPGDSNPY5RSCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515133-B1 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. NEUROGEN CORPORATION 2003-02-04 US disclosed
US-6121260-A Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives NEUROGEN CORPORATION (US) 2000-09-19 US disclosed